| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.099 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |